Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xu, Kailin  [Clear All Filters]
2024
Shi M, Wang J, Huang H, Liu D, Cheng H, Wang X, Chen W, Yan Z, Sang W, Qi K, et al. Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nat Commun. 2024;15(1):3371.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, et al. Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy. Cytotherapy. 2024.
Adzraku SYao, Cao C, Zhou Q, Yuan K, Hao X, Li Y, Yuan S, Huang Y, Xu K, Qiao J, et al. Endothelial Robo4 suppresses endothelial-to-mesenchymal transition induced by irradiation and improves hematopoietic reconstitution. Cell Death Dis. 2024;15(2):159.
Zhu S, Zhang X, Xu K, Liang J, Wang W, Zeng L, Xu K. Loss of NLRP6 expression increases the severity of intestinal injury after syngeneic hematopoietic stem cell transplantation. Ann Hematol. 2024.
Jiang H, Nechipurenko DYu, Panteleev MA, Xu K, Qiao J. Redox regulation of platelet function and thrombosis. J Thromb Haemost. 2024.
Xu K. Sequential infusion of two different chimeric antigen receptor T cells: induction of a deep and durable remission. Blood Sci. 2024;6(1):e00177.
2023
Xia J, Li H, Yan Z, Zhou D, Wang Y, Qi Y, Cao J, Li D, Cheng H, Sang W, et al. Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial. J Clin Oncol. 2023:JCO2201824.
Zhu S, Xu K, Li S, Yu X, Liu Y, Zhang Q, Zeng L, Xu K, Fu C. Assessment of intestinal status in MPL mutant myeloproliferative neoplasms mice model. Int Immunopharmacol. 2023;125(Pt A):111091.
Shao R, Li Z, Xin H, Jiang S, Zhu Y, Liu J, Huang R, Xu K, Shi X. Biomarkers as targets for CAR-T/NK cell therapy in AML. Biomark Res. 2023;11(1):65.
Li X, Zhang J, Li Y, Dai Y, Zhu H, Jiang H, Han Y, Chu X, Sun Y, Ju W, et al. Celastrol inhibits platelet function and thrombus formation. Biochem Biophys Res Commun. 2023;693:149366.
Liu Y, Jie X, Nian L, Wang Y, Wang C, Ma J, Jiang J, Wu Q, Qiao J, Chen W, et al. A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells. Front Immunol. 2023;14:1169071.
Zhou L, Fu W, Wu S, Xu K, Qiu L, Xu Y, Yan X, Zhang Q, Zhang M, Wang L, et al. Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre study. Br J Haematol. 2023.
Chu X, Zhang J, Li Y, Yuan K, Wang X, Gui X, Sun Y, Geng C, Ju W, Xu M, et al. Dimethyl fumarate possesses antiplatelet and antithrombotic properties. Int Immunopharmacol. 2023;120:110381.
Zhang Y, Liu FA, Liang XL, Zhu J, Han L, Shi XD, Cao J, Li Z, Chen W, Xu K, et al. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients. Clin Exp Med. 2023.
Xia J, Li Z, Xu K. Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting. J Hematol Oncol. 2023;16(1):60.
Zhang X, Zhang Y, Liu FA, Zhu J, Liang XL, Shi XD, Han L, Xu K, Cheng H. Red blood cell distribution width as a prognostic factor in patients with aplastic anemia treated with cyclosporin A plus androgen or cyclosporine A alone: a retrospective study. Hematology. 2023;28(1):2240665.
Adzraku SYao, Wang G, Cao C, Bao Y, Wang Y, Smith AOsman, Du Y, Wang H, Li Y, Xu K, et al. Robo4 inhibits gamma radiation-induced permeability of a murine microvascular endothelial cell by regulating the junctions. Cell Mol Biol Lett. 2023;28(1):2.
Cui Y, Yuan T, Wang Y, Zheng D, Qin L, Li S, Jiang Z, Lin S, Guo W, Wang Z, et al. T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity. Cell Rep. 2023;42(7):112797.
Wang X, Zhou Y, Sun Q, Zhang Q, Zhou H, Zhang J, Du Y, Wang Y, Yuan K, Xu L, et al. Thymosin β4 exerts cytoprotective function and attenuates liver injury in murine hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.
2021
Chen W, Su GZ, Xu Y, Guo W, Bhansali R, Pan B, Kong QL, Cheng H, Cao J, Qi K, et al. Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance. Int Immunopharmacol. 2021;94:107503.
Zeng L, Ding S, Yan Z, Chen C, Sang W, Cao J, Cheng H, Xu K. Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2021.
2020
Zhu S, Li H, Liang J, Lv C, Zhao K, Niu M, Li Z, Zeng L, Xu K. Assessment of oral ciprofloxacin impaired gut barrier integrity on gut bacteria in mice. Int Immunopharmacol. 2020;83:106460.
Ju W, Lu W, Bao Y, Sun T, Adzraku SYao, Fu C, Qi K, Zhang X, Li Z, Xu K, et al. Clodronate-Liposomes aggravate irradiation -induced myelosuppression by promoting myeloid differentiation. Int J Radiat Biol. 2020:1-24.
Wang X, Zhang S, Ding Y, Tong H, Xu X, Wei G, Chen Y, Ju W, Fu C, Qi K, et al. p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis. Redox Biol. 2020;34:101569.
Li H, Yin L, Wang Y, Wang X, Shi M, Cao J, Yan Z, Sang W, Cheng H, Zhu F, et al. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment. Bone Marrow Transplant. 2020.

Pages